Who owns Titan Pharmaceuticals?
Who owns Titan Pharmaceuticals?
Top 10 Owners of Titan Pharmaceuticals Inc
| Stockholder | Stake | Total value ($) |
|---|---|---|
| The Vanguard Group, Inc. | 2.07% | 457,645 |
| Morgan Stanley & Co. LLC | 1.61% | 355,652 |
| Citadel Advisors LLC | 0.70% | 154,354 |
| Geode Capital Management LLC | 0.54% | 118,937 |
Is Titan Pharmaceuticals a buy?
Titan Pharmaceuticals has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Where is Titan Pharmaceuticals located?
California
Titan Pharmaceuticals
| Type | Public |
|---|---|
| Industry | Pharmaceuticals |
| Headquarters | California |
| Key people | Executive Chairman, Marc Rubin, MD; President & COO, Kate Beebe Devarney, Ph.D |
| Website | www.titanpharm.com |
What does Ttnp stand for?
TTNP
| Acronym | Definition |
|---|---|
| TTNP | Temporal Transition Network Protocol (wireless mobile) |
| TTNP | Tactical Telephone Numbering Plan |
Will Titan Pharmaceuticals stock go up?
Will Titan Pharmaceuticals, Inc. (de) stock price grow / rise / go up? Yes. The TTNP stock price can go up from 2.110 USD to 2.136 USD in one year.
How high will Titan Pharmaceuticals go?
Titan Pharmaceuticals Inc (NASDAQ:TTNP) The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +228.64% increase from the last price of 2.13.
What is Ttnp stock forecast?
HUMBL, Inc quote is equal to 1.490 USD at 2021-08-09. Based on our forecasts, a long-term increase is expected, the “TSNP” stock price prognosis for 2026-04-28 is 2.288 USD. With a 5-year investment, the revenue is expected to be around +53.52%. Your current $100 investment may be up to $153.52 in 2026.
Is Ttnp worth buying?
Maxim Group is very positive about TTNP and gave it a “Hold – Buy” rating on February 25, 2021. The price target was set to $11.00….Predicted Opening Price for Titan Pharmaceuticals of Monday, August 2, 2021.
| Fair opening price August 2, 2021 | Current price |
|---|---|
| $2.27 | $2.24 (Undervalued) |
Is Tsnp a good stock to invest in?
If you are looking for stocks with good return, HUMBL, Inc can be a profitable investment option. Based on our forecasts, a long-term increase is expected, the “TSNP” stock price prognosis for 2026-04-28 is 2.288 USD. With a 5-year investment, the revenue is expected to be around +53.52%.
What stock took the biggest hit today?
Most Actives
| Company | Price | % Change |
|---|---|---|
| BAC Bank of America Corp | 41.05 | +0.07% |
| F Ford Motor Co | 12.89 | -0.92% |
| T AT Inc | 27.56 | -0.29% |
| WFC Wells Fargo & Co | 44.17 | -0.90% |
What stock has the biggest gain today?
Day Gainers
| Symbol | Name | Price (Intraday) |
|---|---|---|
| CIMEF | CIMC Enric Holdings Limited | 1.4400 |
| MDB | MongoDB, Inc. | 507.41 |
| HIPO | Hippo Holdings Inc. | 5.23 |
| ADGI | Adagio Therapeutics, Inc. | 42.39 |
Who are Titan Pharmaceuticals and what do they do?
Titan Pharmaceuticals. Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura.
When does Titan Pharmaceuticals file its 10-K?
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that it has filed its annual report on Form 10-K for the fiscal year ended December 31, 2020 with the Securities and Exchange Commission (“SEC”).
How much money did Titan Pharmaceuticals raise in IPO?
In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds.
When do Titan Pharmaceuticals 2019 results come out?
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that its fourth quarter and full year 2019 financial results will be released after market close on Monday, March 30, 2020.